iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Entero Healthcare Solutions Files IPO Prospectus with SEBI

14 Sept 2023 , 09:13 PM

Entero Healthcare Solutions, a healthcare products distributor supported by OrbiMed, took a significant step by submitting its draft red herring prospectus to the capital markets regulator SEBI on September 13. Here are the key details:

The company's initial public offering (IPO) consists of a fresh issuance of shares valued at Rs 1,000 crore by the company itself. Additionally, there is an offer-for-sale (OFS) of 85.57 lakh equity shares, which will be divested by 19 selling shareholders, including promoters Prabhat Agrawal, OrbiMed Asia III Mauritius, and Prem Sethi.

OrbiMed Asia III Mauritius, a corporate promoter owned by the US-based healthcare-focused investment firm OrbiMed, holds a significant 58.70 percent shareholding in the company. Meanwhile, individual promoters Prabhat Agrawal and Prem Sethi own 11.38 percent and 6.46 percent shares in the company, respectively.

The second-largest shareholder in Entero Healthcare Solutions is Prasid Uno Family Trust, represented by trustees Surbhi Singh and Universal Trustee, holding a 20.04 percent stake.

The Mumbai-based company is also considering raising Rs 200 crore through private placement, preferential allotment, or a rights issue before finalizing the red herring prospectus with the Registrar of Companies (ROC).

Proceeds from the fresh issue will primarily be used to repay debts amounting to Rs 123.7 crore and fulfill long-term working capital requirements of Rs 600 crore. Any remaining funds will be allocated towards inorganic growth strategies through acquisitions and general corporate purposes.

Established in 2018 by Prabhat Agrawal and Prem Sethi, Entero Healthcare claims a spot among the top three healthcare products distributors in India, based on its FY22 revenue. In FY23, the company reported an operating income of Rs 2,522.07 crore.

Entero Healthcare operates as a pharmaceutical and medical device distributor, serving a diverse customer base comprising retail pharmacies and hospitals. The company boasts a nationwide network of 73 warehouses and a robust technology infrastructure. Over the course of FY23, it catered to more than 81,400 retail customers and over 3,400 hospital customers, marking significant growth compared to FY22 when it served 64,200 retail customers and 2,500 hospital customers.

While Entero Healthcare has reported losses in previous fiscal years, it showed promising signs in FY23, narrowing its net loss to Rs 11.1 crore from Rs 29.44 crore. Additionally, its revenue demonstrated robust growth, surging 31 percent year-on-year to reach Rs 3,300 crore during FY23.

The IPO's merchant bankers include ICICI Securities, DAM Capital Advisors, Jefferies India, JM Financial, and SBI Capital Markets.

Entero Healthcare Solutions

Related Tags

  • Entero Healthcare Solutions
  • Entero Healthcare Solutions DRHP
  • Entero Healthcare Solutions IPO
  • Entero Healthcare Solutions SEBI
  • SEBI
sidebar mobile


Read More

Most Read News

Markets end the day on a flat note
24 May 2024|04:22 PM
Indian markets trade in green
24 May 2024|04:28 PM
Read More
Knowledge Centerplus

Logo IIFL Customer Care Number
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

Knowledge Centerplus

Follow us on


2024, IIFL Securities Ltd. All Rights Reserved

  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.